Related Experiment Video
Updated: Sep 27, 2025

07:41
A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
Published on: March 8, 2022
2.6K
[Gene expression profiling in melanoma diagnostics: problems and future application in clinical practice]
N V Palkina1, T G Ruksha1, V A Khorzhevskii1
1Prof. V.F. Voino-Yasenetsky Krasnoyarsk State Medical University, Krasnoyarsk, Russia.
Arkhiv Patologii
|April 14, 2022
Summary
Pathologists face challenges diagnosing melanoma due to complex features and unreliable markers. Gene expression analysis offers a promising, objective alternative for diagnosing malignant and melanocytic neoplasms.
Area of Science:
- Oncology
- Pathology
- Molecular Biology
Background:
- Melanoma diagnosis is challenging for pathologists due to overlapping morphological features.
- Current immunohistochemical markers show insufficient effectiveness for accurate diagnosis and differential diagnosis.
- Histopathology faces limitations in distinguishing certain malignant neoplasms, including melanocytic ones.
Purpose of the Study:
- To review modern alternative diagnostic methods for malignant tumors.
- To explore gene expression assessment as a potential diagnostic tool.
- To evaluate the future clinical application of molecular diagnostic tests in pathology.
Main Methods:
- Review of current literature on diagnostic methods for malignant neoplasms.
- Analysis of gene expression assessment techniques.
- Evaluation of objectivity and reliability of molecular markers.
Main Results:
- Gene expression analysis presents a modern approach to diagnosing malignant tumors.
- These methods offer improved objectivity and reliability compared to some existing markers.
- Potential for integration with histopathological methods is highlighted.
Conclusions:
- Gene expression profiling may supplement histopathology in diagnosing melanocytic neoplasms.
- This approach could shift diagnostic paradigms by incorporating molecular information.
- Future clinical application of these advanced diagnostic tests is anticipated.

